Cleared Traditional

Maverick RNP Assay and Maverick Diagnostic System

K191085 · Genalyte, Inc. · Immunology
Oct 2019
Decision
184d
Days
Class 2
Risk

About This 510(k) Submission

K191085 is an FDA 510(k) clearance for the Maverick RNP Assay and Maverick Diagnostic System, a Anti-rnp Antibody, Antigen And Control (Class II — Special Controls, product code LKO), submitted by Genalyte, Inc. (San Diego, US). The FDA issued a Cleared decision on October 25, 2019, 184 days after receiving the submission on April 24, 2019. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5100.

Submission Details

510(k) Number K191085 FDA.gov
FDA Decision Cleared SESE
Date Received April 24, 2019
Decision Date October 25, 2019
Days to Decision 184 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code LKO — Anti-rnp Antibody, Antigen And Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.5100

Similar Devices — LKO Anti-rnp Antibody, Antigen And Control

All 22
EUROIMMUN EUROLINE ENA PROFILE 9AG (IGG)
K140224 · Euroimmun US · Dec 2014
EUROIMMUN ANTI-NRNP/SM ELISA (IGG)
K123261 · Euroimmun US · Jun 2013
ELIA RNP70 IMMUNOASSAY, ELIA SCI-70 IMMUNOASSAY AND ELIA JO-1 IMMUNOASSAY, MODELS 14-5511-01, 14-5506-01 AND 14-5507-01
K083117 · Phadia US, Inc. · May 2009
MODIFICATION TO FIDIS CONNECTIVE 10*, MODEL MX006
K071210 · Biomedical Diagnostics (Bmd) SA · Dec 2007
RHIGENE MESACUP-2 TEST RNP, MODEL M7741
K022017 · Rhigene, Inc. · Aug 2002
RHIGENE MESACUP2 TEST- RNP
K000752 · Rhigene, Inc. · May 2000